Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures
- 28 June 2002
- journal article
- research article
- Published by Wiley in Journal of Periodontal Research
- Vol. 37 (3) , 196-203
- https://doi.org/10.1034/j.1600-0765.2002.00663.x
Abstract
Matrix metalloproteinases (MMPs), produced by both infiltrating and resident cells of the periodontium, play a role in physiologic and pathologic events. It is recognized that an imbalance between activated MMPs and their endogenous inhibitors leads to pathologic breakdown of the extracellular matrix during periodontitis. To date, little is known about the regulation of MMP synthesis and secretion in human periodontal ligament fibroblasts (PDLFs). The purpose of this study was to examine the effects of cytokines, pharmacological agents (protein synthesis inhibitor and protein kinase C inhibitors) and predominant periodontal pathogens (Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis) on MMP production in human PDLFs using gelatin zymography. The gelatin zymograms revealed that the main gelatinase secreted by human PDLFs migrated at 72 kDa and represents MMP‐2. Minor gelatinolytic bands were also observed at 92 kDa regions that correspond to MMP‐9. We found that A. actinomycetemcomitans, P. gingivalis and IL‐1α can elevate MMP‐2 secretion in human PDLFs. These results indicate that periodontal pathogens and inflammatory cytokines play an important role in tissue destruction and disintegration of extracellular matrix in periodontal diseases. Thus, activation of MMPs may be one of the distinct host degradative pathways in the pathogenesis of periodontitis. In addition, H7, staurosporine, cycloheximide and TGF‐β could suppress MMP‐2 production. Agents that target protein synthesis or the protein kinase C pathway in human PDLFs inhibit MMP‐2 production, and such inhibition may contribute to the pathogenesis of periodontal inflammation. Taken together, these findings suggest a possible new therapeutic approach, involving the use of drugs that modify host‐response mechanisms to suppress or inhibit MMP‐mediated tissue destruction.Keywords
This publication has 29 references indexed in Scilit:
- MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cellsHepatology, 1999
- Interleukin‐1β induction of tissue inhibitor of metalloproteinase (TIMP‐1) is functionally antagonized by prostaglandin E2 in human synovial fibroblastsJournal of Cellular Biochemistry, 1995
- Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patientsJournal of Periodontal Research, 1994
- Role of cytokines and inflammatory mediators in tissue destructionJournal of Periodontal Research, 1993
- Production of gelatin-degrading matrix metalloproteinases (‘type IV collagenases’) and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor αBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Microbial mechanisms in the pathogenesis of destructive periodontal diseases: a critical assessmentJournal of Periodontal Research, 1991
- Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: Evidence that breakdown is mediated by metal loproteinasesJournal of Periodontal Research, 1989
- Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesisJournal of Oral Pathology & Medicine, 1986
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986
- 1-(5-isoquinol inesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase c in rabbit plateletsBiochemical and Biophysical Research Communications, 1984